PDPL
- Series
- BE
- F&O
- No
- Status
- Inactive since 02 Apr 2019
Source: NSE equity master · as of 01 Apr 2019
- 10 Aug 2022 17:38PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange about resignation of Pooja Choukse as Company Secretary of the company w.e.f. 31-Jul-2022.
- 02 Feb 2022 17:21PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange about appointment of Ms Pooja Choukse as Company Secretary/Compliance Officer of the Company w.e.f. from 01/02/2022.
- 02 Feb 2022 17:10PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Director(s) of the company.
- 01 Jan 2022 17:00PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Ms Suruchi Maheshwari as Company Secretary & Compliance Officer of the company w.e.f. January 01, 2022.
- 30 Nov 2021 18:39PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Mrs Deepali Garehwal as Non- Executive Independent Director of the company w.e.f. November 30, 2021.
- 24 Sept 2021 18:18PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Director(s) of the company.
- 20 Sept 2020 09:24PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding reappointment of Mr. Manish Verma, Independent Director for a period of Second Term
- 20 Sept 2020 09:21PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding reappointment of Mr. Govind Das Garg
- 31 Aug 2019 22:01PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Reappointment of Director of the company.
- 31 Aug 2019 21:58PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Reappointment of Director of the company.
- 11 Jun 2019 18:29PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Director(s) of the company.
- 23 Apr 2019 11:55PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Appointment of Mr Vinod Kumar Gupta as Chief Financial Officer of the company w.e.f. April 23, 2019.
- 20 Apr 2019 17:33PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Mr Balkrishna Vinayak Chaubal as Nominee Director of the company w.e.f. March 27, 2019.
- 27 Feb 2019 16:30PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Cessation of Mr Vinod Kumar Gupta as Managing Director of the company w.e.f. February 27, 2019.
- 07 Dec 2018 11:09PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Appointment of Ms Suruchi Maheshwari as Company Secretary & Compliance Officer of the company w.e.f. December 06, 2018.
- 21 Sept 2018 16:34PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Mrs Aradhana Kulkarni as Company Secretary & Compliance Officer of the company w.e.f. September 16, 2018.
- 29 Jun 2018 16:34PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Appointment of Mr Manish Verma as Independent Director of the company w.e.f. Jun 29, 2018.
- 13 Jun 2018 15:35PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Director(s) of the company.
- 29 Sept 2017 12:51PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange regarding Change in Auditors of the company.
- 02 May 2017 08:54PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange the resignation of Mr. Dilip Kumar Panchaity as an Independent Director on the Board of the Company w.e.f May, 01, 2017 pursuant to intimation of such resignation received by the Company on May 01, 2017.
- 14 Nov 2016 15:54PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on November 14, 2016 had considered & approved the appointment of Mr. Sandeep Vyas as an additional and Independent director on the Board of the Company.
- 14 Oct 2015 17:41PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange that there is a change in the company's directorate due to appointment of Mr. Balkrishna V. Chaubal as Nominee Director on the Board of the Company w.e.f October 14, 201 5 pursuant to intimation of appointment received by the Company on October 14, 2015.
- 04 Jul 2014 14:48PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange that Mr. Satish Moreshwar Joshi, nominee director of the company has tendered his resignation from directorship of the company w.e.f. June 30, 2014 due to his personal priorities.
- 22 Apr 2014 12:32PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange that Ms. Aradhana Kulkarni has been appointed as Company Secretary and Compliance Officer of the Company w.e.f. April 18, 2014 by the management of the Company.
- 18 Mar 2014 18:20PDF · -Management
Parenteral Drugs (India) Limited has informed the Exchange that the proposed resignation of Mr.Yogesh Khakre from the post of Company Secretary and Compliance Officer of the Company w.e.f. March 01, 2014 has been approved by the management of the Company on March 18, 2014. Consequently he has ceased to be the Company Secretary and Compliance Officer of the Company w.e.f. March 01, 2014.
- 16 Sept 2013 15:52Management
Parenteral Drugs (India) Limited has informed the Exchange that "Shri Satish Moreshwar Joshi, the Nominee of State Bank of India be and is hereby appointed as a Nominee Director of the Company w.e.f. 16.08.2013 in terms of letter of approval by CDR-EG."
- 06 May 2013 09:00Management
Parenteral Drugs (India) Limited has informed the Exchange that the Company has appointed Mr. Yogesh Khakre as the Company Secretary & Compliance Officer of the Company w.e.f. April 01, 2013 and Ms. Archna Agar has submitted her resignation from the post of Company Secretary and Compliance Officer w.e.f. March 31, 2013. Consequently, she has ceased to be the designated Compliance Officer of the Company w.e.f. that date.
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries